Outsmarting Resistant Infections

EP. 1: An Overview of Multidrug-Resistant Bacterial Infections

February 9th 2018

EP. 2: Understanding the Causes and Impact of MDR Infections

February 9th 2018

EP. 3: MDR Infections: Current Pathogen and Treatment Paradigm

February 9th 2018

EP. 4: Gram-Negative Nosocomial Infections: Systemic Risk

February 9th 2018

EP. 5: Factors in Choosing Therapy for Gram-Negative NIs

February 9th 2018

EP. 6: Diagnostic Tests for Gram-Negative Nosocomial Infections

February 9th 2018

EP. 7: Gram-Negative NIs: Vabomere and the TANGO II Study

February 9th 2018

EP. 8: Gram-Negative NIs: Cephalosporin/β-Lactamase Inhibitors

February 9th 2018

EP. 9: Understanding Gram-Positive Nosocomial Infections

February 9th 2018

EP. 10: Selecting Lipoglycopeptide Therapy for Gram-Positive NIs

February 9th 2018

EP. 11: Gram-Positive NIs: Nuancing Lipoglycopeptide Therapy

February 9th 2018

EP. 12: Gram-Positive NIs: Costs of Lipoglycopeptide Therapy

February 9th 2018

EP. 13: MDR Infections: Overview of Antimicrobial Stewardships

February 9th 2018

EP. 14: Importance of Technology & Data Within Antibiotic Stewardship Programs

February 9th 2018

EP. 15: Antimicrobial Stewardship Programs: Goals and Challenges

February 9th 2018

EP. 16: Multidrug-Resistant Bacterial Infections: Key Messages

February 9th 2018

Trending on Contagion Live

Two More Food Recalls: Frozen Blueberries, Alfalfa Sprouts Sicken Dozens Across the US

FDA Approves 2026-2027 Pfizer-BioNTech COVID-19 Vaccine

Clinical Insights and the Geopolitics Surrounding the Ongoing Ebola Outbreak

Venky Soundararajan, PhD: What the Semaglutide-COVID Data Can't Yet Show

Semaglutide Linked to Lower COVID-19, Influenza Severity in Study